SHORT MINI-FUTURE - BAYER | Market Closed - Deutsche Boerse AG 19:04:41 04/06/2024 BST | ||
| 4.26 EUR | +0.24% |
|
| Current month | -0.70% | ||
| 1 month | -0.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
Latest news about BAYER AG
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 4.26 | +0.24% |
| 03/06/24 | 4.25 | -0.70% |
| 31/05/24 | 4.28 | -0.47% |
| 30/05/24 | 4.3 | -2.05% |
| 29/05/24 | 4.39 | +1.62% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 07:04 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | 
Vontobel
|
| WKN | VU3H05 |
| ISIN | DE000VU3H058 |
| Date issued | 13/02/2023 |
| Strike | 70.94 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.5 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.58 € |
|---|---|
| Lowest since issue | 1.17 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.34
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.30%
- Stock Market
- Certificates
- Certificat